AQR Capital Management
MBIO icon

AQR Capital Management’s Mustang Bio MBIO Stock Holding History

AQR Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-48
Closed -$21K – 2267
2022
Q2 		$21K Buy
48
+26
+118% +$14.4K ﹤0.01% 2163
2022
Q1 		$16K Buy
22
+6
+38% +$4.93K ﹤0.01% 2206
2021
Q4 		$20K Hold
16
– – ﹤0.01% 2188
2021
Q3 		$32K Hold
16
– – ﹤0.01% 2232
2021
Q2 		$39K Sell
16
-51
-76% -$125K ﹤0.01% 2211
2021
Q1 		$168K Buy
+67
New +$199K ﹤0.01% 2129
2020
Q4 		– Sell
-98
Closed -$231K – 2235
2020
Q3 		$231K Buy
+98
New +$242K ﹤0.01% 2011

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management's MBIO Position: Q3 2022 in Review

AQR Capital Management sold out of Mustang Bio (MBIO) in Q3 2022, closing a stake of 48 shares — an estimated $21K sold.

AQR Capital Management first reported a position in MBIO in Q3 2020 and held it in 7 quarters. The position peaked at $231K in Q3 2020. 67 funds tracked by Wall St. Rank hold MBIO as of Q3 2022.

  • AQR Capital Management reported no remaining Mustang Bio position as of Q3 2022 after selling out during the quarter.
  • AQR Capital Management sold 48 Mustang Bio shares in Q3 2022, an estimated $21K.
  • AQR Capital Management first reported a position in Mustang Bio in Q3 2020 and held it in 7 quarters.
  • AQR Capital Management's Mustang Bio position peaked at $231K in Q3 2020.
  • 67 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2022.

Based on AQR Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.